Ikarian Capital’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-67
| Closed | -$215K | – | 169 |
|
|
2022
Q1 | $215K | Buy |
67
+3
| +5% | +$9.63K | 0.03% | 123 |
|
|
2021
Q4 | $398K | Hold |
64
| – | – | 0.06% | 107 |
|
|
2021
Q3 | $589K | Sell |
64
-9
| -12% | -$82.8K | 0.04% | 116 |
|
|
2021
Q2 | $739K | Sell |
73
-114
| -61% | -$1.15M | 0.06% | 122 |
|
|
2021
Q1 | $3.59M | Buy |
+187
| New | +$3.59M | 0.12% | 64 |
|